Canopy Growth (TSE:WEED – Free Report) had its price objective trimmed by ATB Capital from C$3.20 to C$1.60 in a research report released on Tuesday morning,BayStreet.CA reports. The firm currently has an underperform rating on the stock.
Separately, Canaccord Genuity Group decreased their price target on shares of Canopy Growth from C$2.50 to C$1.50 and set a “sell” rating on the stock in a research report on Monday, February 10th.
Read Our Latest Stock Analysis on WEED
Canopy Growth Price Performance
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Stories
- Five stocks we like better than Canopy Growth
- Transportation Stocks Investing
- Among the Market’s Most Shorted: 2 Firms With +40% Short Interest
- What Are Trending Stocks? Trending Stocks Explained
- Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next
- Investing in Commodities: What Are They? How to Invest in Them
- Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.